Aziz Sawaf - 20 May 2025 Form 4 Insider Report for Theravance Biopharma, Inc. (TBPH)

Role: SVP & CHIEF FINANCIAL OFFICER
Signature: /s/ Brett A. Grimaud, Attorney-in-Fact
Issuer symbol: TBPH
Transactions as of: 20 May 2025
Net transactions value: -$88,339
Form type: 4
Filing time: 22 May 2025, 18:42:52 UTC
Previous filing: 04 Mar 2025
Next filing: 22 Aug 2025
SEC: View on sec.gov

Reporting Owners (1)

Name	Relationship	Address	Signature	Signature date	CIK
Sawaf Aziz	SVP & CHIEF FINANCIAL OFFICER	C/O THERAVANCE BIOPHARMA US, LLC, 901 GATEWAY BLVD, SOUTH SAN FRANCISCO	/s/ Brett A. Grimaud, Attorney-in-Fact	22 May 2025	0001961289

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	TBPH	Ordinary Shares	Tax liability	$88,339	-9,348	-2.5%	$9.45	364,790	20 May 2025	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Shares withheld to satisfy tax obligations arising out of the vesting of previously granted restricted stock units. The share withholding transaction was with the issuer and did not involve an open market transaction.